Association of combination antiretroviral therapy with risk of neurological diseases in patients with HIV/AIDS in Taiwan: a nested case-control study

Heterogeneous neurocognitive impairment remains an important issue, even in the era of combination antiretroviral therapy (cART), with an incidence ranging from 15% to 65%. Although ART drugs with higher penetration scores to the central nervous system (CNS) show better HIV replication control in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Chen-Hsing, Chiou, Jian-Shiun, Ho, Mao-Wang, Tien, Ni, Li, Te-Mao, Chiu, Mu-Lin, Tsai, Fuu-Jen, Wu, Yang-Chang, Chou, I-Ching, Lu, Hsing-Fang, Lin, Ting-Hsu, Liao, Chiu-Chu, Huang, Shao-Mei, Liang, Wen-Miin, Lin, Ying-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285306/
https://www.ncbi.nlm.nih.gov/pubmed/37361207
http://dx.doi.org/10.3389/fphar.2023.1110605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285306/
https://www.ncbi.nlm.nih.gov/pubmed/37361207
http://dx.doi.org/10.3389/fphar.2023.1110605

Ejemplares similares